Article Details

AstraZeneca drug fails one main goal in study of chronic immune disease - PharmaLive

Retrieved on: 2022-10-25 15:13:58

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca drug fails one main goal in study of chronic immune disease - PharmaLive. View article details on HISWAI: https://www.pharmalive.com/astrazeneca-drug-fails-one-main-goal-in-study-of-chronic-immune-disease/

Excerpt

Oct 25 (Reuters) – Drugmaker AstraZeneca (AZN.L) said on Tuesday that its asthma drug Fasenra failed to meet one of two main goals of a late-stage ...

Article found on: www.pharmalive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up